Literature DB >> 19077486

[Correlation between clinical symptoms and radiologic findings before and after pneumatic balloon dilatation for achalasia].

Jong Tae Moon1, In Su Jung, Young Shin Kim, Seung Hyun Cho, Hyojin Park, Sang In Lee.   

Abstract

BACKGROUND/AIMS: We investigated the risk factors for short-term recurrence and analyzed the correlation between subjective clinical symtoms and objective radiological findings in patients with achalasia undergoing pneumatic balloon dilatation.
METHODS: Twenty patients who were treated by pneumatic balloon dilatation were enrolled. We compared prospectively various indices before and after the treatment as follows: 1) Eckardt symptom score and dysphagia grade, 2) The ratio of the maximal width in mid-esophageal lumen to the minimal width in distal esophagus around lower esophageal sphincter, and 3) the percentage of maximum activity retained in the esophagus at 30 seconds and T in esophageal scan two days after the treatment.
RESULTS: 1) Clinical indices and radiologic indices significantly improved after pneumatic dilatation. 2) There was no significant correlation between the clinical indices and the radiologic indices before and after the treatment. 3) The difference percentage of clinical indices did not show significant correlation with the difference percentage of the radiologic indices. 4) Compared to the group above 20% in the difference percentage of 30 second residual fraction, the one below 20% had a four-fold risk in short-term recurrence.
CONCLUSIONS: Clinical symptoms and radiologic indices significantly improve after pneumatic dilatation but have no significant correlation to each other. The group below 20% in the difference percentage of 30 second residual fraction has a high risk of recurrence and may need careful examination and early repeated pneumatic dilation.

Entities:  

Mesh:

Year:  2008        PMID: 19077486

Source DB:  PubMed          Journal:  Korean J Gastroenterol        ISSN: 1598-9992


  7 in total

1.  Correlation Between Timed Barium Esophagogram and Esophageal Transit Scintigraphy Results in Achalasia.

Authors:  Yoo Mi Park; Han Ho Jeon; Jae Jun Park; Jie-Hyun Kim; Young Hoon Youn; Hyojin Park
Journal:  Dig Dis Sci       Date:  2015-04-30       Impact factor: 3.199

2.  Pre-treatment Eckardt score is a simple factor for predicting one-year peroral endoscopic myotomy failure in patients with achalasia.

Authors:  Yutang Ren; Xiaowei Tang; Yanmin Chen; Fengping Chen; Yingying Zou; Zhiliang Deng; Jianuan Wu; Yan Li; Silin Huang; Bo Jiang; Wei Gong
Journal:  Surg Endosc       Date:  2016-11-18       Impact factor: 4.584

3.  For patients with primary achalasia the clinical success of pneumatic balloon dilatation can be predicted from the residual fraction of radionuclide during esophageal transit scintigraphy.

Authors:  Han Ho Jeon; Young Hoon Youn; Kwangwon Rhee; Jie-Hyun Kim; Hyojin Park; Jeffrey L Conklin
Journal:  Dig Dis Sci       Date:  2013-10-29       Impact factor: 3.199

4.  Patient-Reported Outcomes in Eosinophilic Esophagitis and Achalasia.

Authors:  Alain Schoepfer; Alex Straumann; Ekaterina Safroneeva
Journal:  Curr Treat Options Gastroenterol       Date:  2016-03

5.  Long-term outcomes of balloon dilation versus botulinum toxin injection in patients with primary achalasia.

Authors:  Ho Eun Jung; Joon Seong Lee; Tae Hee Lee; Jin Nyoung Kim; Su Jin Hong; Jin Oh Kim; Hyeon Geon Kim; Seong Ran Jeon; Joo Young Cho
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

6.  Functional restoration of the esophagus after peroral endoscopic myotomy for achalasia.

Authors:  Cheal Wung Huh; Young Hoon Youn; Hyunsoo Chung; Yong Chan Lee; Hyojin Park
Journal:  PLoS One       Date:  2017-05-23       Impact factor: 3.240

7.  An evidence of esophageal decompensation in patients with achalasia in the view of its subtype: a retrospective study.

Authors:  Kwangwon Rhee; Hanho Jeon; Jie-Hyun Kim; Young Hoon Yoon; Hyojin Park; Sang In Lee
Journal:  J Neurogastroenterol Motil       Date:  2013-07-08       Impact factor: 4.924

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.